Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pam2CSK4 acetate and ODN M362 combination × Other hematologic neoplasm × 30 days × Clear all

Sponsor

Interventions

venetoclax 96 Specimen Handling 57 Azacitidine 57 Cytarabine 49 Biopsy 46 Cyclophosphamide 43 fludarabine 34 Daunorubicin 24 Rituximab 23 Injections 21 Vincristine 19 Decitabine 19 Magnetic Resonance Spectroscopy 18 fludarabine phosphate 16 Prednisone 16 Methotrexate 16 ibrutinib 15 Granulocyte Colony-Stimulating Factor 15 Whole-Body Irradiation 14 Doxorubicin 14 obinutuzumab 13 CPX-351 13 Stem Cell Transplantation 12 Filgrastim 12 Melphalan 11 Idarubicin 11 Dexamethasone 11 blinatumomab 10 Etoposide 10 Busulfan 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡